Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
5.43
+0.21 (4.02%)
At close: May 30, 2025, 4:00 PM
5.50
+0.07 (1.29%)
After-hours: May 30, 2025, 6:09 PM EDT
Liminatus Pharma Statistics
Total Valuation
LIMN has a market cap or net worth of $141.26 million. The enterprise value is $161.18 million.
Market Cap | 141.26M |
Enterprise Value | 161.18M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
LIMN has 26.01 million shares outstanding. The number of shares has increased by 215.62% in one year.
Current Share Class | 26.01M |
Shares Outstanding | 26.01M |
Shares Change (YoY) | +215.62% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 23.72% |
Owned by Institutions (%) | n/a |
Float | 7.45M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.21
Current Ratio | 0.21 |
Quick Ratio | 0.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -9.82 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -54.40% |
Return on Invested Capital (ROIC) | -468.22% |
Return on Capital Employed (ROCE) | 17.22% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 0.25 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 29.85 |
Average Volume (20 Days) | 26,258 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -3.33M |
Pretax Income | n/a |
Net Income | -3.55M |
EBITDA | n/a |
EBIT | -3.33M |
Earnings Per Share (EPS) | -$0.03 |
Balance Sheet
The company has $56,000 in cash and $19.97 million in debt, giving a net cash position of -$19.92 million or -$0.77 per share.
Cash & Cash Equivalents | 56,000 |
Total Debt | 19.97M |
Net Cash | -19.92M |
Net Cash Per Share | -$0.77 |
Equity (Book Value) | -19.34M |
Book Value Per Share | -0.17 |
Working Capital | -19.47M |
Cash Flow
Operating Cash Flow | -1.45M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LIMN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -215.62% |
Shareholder Yield | -215.62% |
Earnings Yield | -2.51% |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |